Pharmaceutical company pays $54 million in settlement for FCA violation

On January 6, Teva Pharmaceuticals agreed to pay $54 million to settle allegations that the company violated the False Claims Act[1] and the Anti-Kickback Statute[2] by providing unlawful compensation to physician speakers. The allegations were based on whistleblowers’ claims made in 2013.

This document is only available to members. Please log in or become a member.
 


Would you like to read this entire article?

If you already subscribe to this publication, just log in. If not, let us send you an email with a link that will allow you to read the entire article for free. Just complete the following form.

* required field